| 1 |
Reissig CJ, Strain EC, Griffiths RR. Caffeinated energy drinks - a growing problem. Drug Alcohol Depend 2009; 99:1-10.
doi: 10.1016/j.drugalcdep.2008.08.001
pmid: 18809264
|
| 2 |
Higgins JP, Tuttle TD, Higgins CL. Energy beverages: content and safety. Mayo Clin Proc 2010; 85:1033-1041.
doi: 10.4065/mcp.2010.0381
pmid: 21037046
|
| 3 |
Petit A, Levy F, Lejoyeux M, Reynaud M, Karila L. Energy drinks: an unknown risk. Rev Prat 2012; 62:673-678.
pmid: 22730801
|
| 4 |
Wolk BJ, Ganetsky M, Babu KM. Toxicity of energy drinks. Curr Opin Pediatr 2012; 24:243-251.
doi: 10.1097/MOP.0b013e3283506827
|
| 5 |
Clauson KA, Shields KM, McQueen CE, Persad N. Safety issues associated with commercially available energy drinks. J Am Pharm Assoc 2008; 48:e55-63.
doi: 10.1331/JAPhA.2008.07055
|
| 6 |
Tintinalli JE, Stapczynski JS, Cline DM, Cydulka RK, Meckler GD. Tintinalli's Emergency Medicine. 7th Edition. McGraw Hill Companies 2011.
|
| 7 |
Worthley MI, Prabhu A, De Sciscio P, Schultz C, Sanders P, Willouqhby SR. Detrimental Effects of Energy Drink Consumption on Platelet and Endothelial Function. Am J Med 2010; 123:184-187.
doi: 10.1016/j.amjmed.2009.09.013
pmid: 20103032
|
| 8 |
Böttcher M, Czernin J, Sun KT, Phelps ME, Schelbert HR. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med 1995; 36:2016-2021.
pmid: 7472591
|
| 9 |
Namdar M, Koepfli P, Grathwohl R, Siegrist PT, Klainguti M, Schepis T. et al. Caffeine decreases exercise-induced myocardial flow reserve. J Am Coll Cardiol 2006; 47:405-410.
doi: 10.1016/j.jacc.2005.08.064
pmid: 16412869
|
| 10 |
Happonen P, Voutilainen S, Salonen JT. Coffee drinking is dose-dependently related to the risk of acute coronary. Events in middle-aged men. J Nutr 2004; 134:2381-2386.
pmid: 15333732
|
| 11 |
Tavani A, Bertuzzi M, Negri E, Sorbara L, La Vecchia C. Alcohol, smoking, coffee and risk of non-fatal acute myocardial infarction in Italy. Eur J Epidemiol 2001; 17:1131-1137.
doi: 10.1023/A:1021276932160
|
| 12 |
Macdonald N, Hamilton R, Malloy P, Moride Y. Shearer J Nov 10, 2010. Report by the Expert Panel on Caffeinated Energy Drinks.
|
| 13 |
Pilgrim JL, Gerostamoulos D, Woodford N, Drummer OH. Serotonin toxicity involving MDMA (ecstasy) and moclobemide. Forensic Sci Int 2012; 215:184-188.
doi: 10.1016/j.forsciint.2011.04.008
|
| 14 |
Schifano F. A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities. Psychopharmacology (Berl) 2004; 173:242-248.
doi: 10.1007/s00213-003-1730-5
|
| 15 |
Vuori E, Henry JA, Ojanperä I, Nieminen R, Savolainen T, Wahlsten P, Jäntti M. Death following ingestion of MDMA (ecstasy) and moclobemide. Addiction 2003; 98:365-368.
doi: 10.1046/j.1360-0443.2003.00292.x
pmid: 12603236
|
| 16 |
Sano R, Hasuike T, Nakano M, Kominato Y, Itoh H. A fatal case of myocardial damage due to misuse of the "designer drug" MDMA. Leg Med (Tokyo) 2009; 11:294-297.
doi: 10.1016/j.legalmed.2009.09.003
|
| 17 |
Lai TI, Hwang JJ, Fang CC, Chen WJ. Methylene 3, 4 Dioxymethamphetamine- Induced Acute Myocardial Infarction. Ann Emerg Med 2003; 42:759-762.
doi: 10.1016/S0196-0644(03)00511-0
|
| 18 |
Bassi S, Rittoo D. Ecstacy and chest pain due to coronary artery spasm. Int J Cardiol 2005; 99:485-487.
doi: 10.1016/j.ijcard.2004.12.007
|
)
